UNSPSC 51422309: Difluprednate

This classification denotes a therapeutic glucocorticoid with the molecular formula C27H34F2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S8A06QG2QE, chemically known as 21-(acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione (6alpha,11beta)- but generally known as difluprednate, which bears US NIH Compound Identifier 32037. European Medicines Agency schedules Difluprednate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07131MIG.

UNSPSC 51422309 Difluprednate, a Commodity code, nominally addresses pharmaceutical products, but the recent state and local procurement activity tagged under it does not reflect difluprednate procurement. Seminole County, Florida solicited naloxone and drug deactivation systems through a competitive IFB process, a mismatch suggesting the code is either misapplied to the procurement notice or the taxonomy does not granularly capture naloxone and harm-reduction equipment as distinct commodities. The source contains no evidence of difluprednate being procured by state or local governments, nor does it support activity across multiple jurisdictions or geographic regions.

The single recent opportunity on record is Seminole County's IFB60459723LAS, posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid deadline was July 26, 2023. The procurement required electronic submission through the county's e-Procurement Portal, with bidders responsible for all shipping and delivery costs and subject to E-Verify compliance and drug-free workplace certification. The contract offered a two-year initial term with an optional one-year renewal and was potentially funded through FEMA, introducing federal compliance requirements. Without additional recent opportunities under this Commodity code, no reliable characterization of issuing-body type, geographic spread, or representative market activity is supported.